5.2
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
View/Download PDF

Translate this page into:

Original Article
:19;
7012025
doi:
10.25259/AJC_701_2025

Magnetic aptamer-functionalized electrochemical nano-biosensor for the detection of circulating tumor DNA

School of Medicine, Jiangsu University, Zhenjiang, Jiangsu, China
The People’s Hospital of Danyang, Affiliated Danyang Hospital of Nantong University, Danyang, Jiangsu, China
School of Pharmacy, Jiangsu University, Zhenjiang, Jiangsu, China
Affiliated Kunshan Hospital, Jiangsu University, Kunshan, Jiangsu, China

†Authors have contributed equally to this work and share first authorship.

*Corresponding author: E-mail address: luckystar_lrj@ujs.edu.cn (R. Liu)

Licence
This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License, which allows others to remix, transform, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.

Abstract

In this work, a novel hydrothermal-calcination process was introduced for the fabrication of sheet-like α-Fe2O3/Fe3O4 magnetic nanocomposites with an average diameter of 220 nm, average thickness of 130 nm, and saturation magnetization of 27.6 emu∙g-1. With the nanosheets as the precursors, the α-Fe2O3/Fe3O4@Au-ssDNA/BSA probes with label-free and magnetically induced self-assembly were constructed for the detection of circulating tumor DNA. The probes revealed excellent linear relationship as I = -2.62 lgCctDNA+138.35 (the linear range of 10 pM–1 μM for the concentration of circulating tumor DNA) with an R2 of 0.998, lower limit of detection of 229 fM, and limit of quantification of 763 fM. The biosensors revealed superior reproducibility (relative standard deviation of 1.13%), excellent stability (the detection errors of -0.97%–1.47% in 14 days), and high selectivity, suggesting the significant clinical application value in the detection of circulating tumor DNA for the biosensors.

Keywords

α-Fe2O3/Fe3O4 magnetic nanocomposites
Circulating tumor DNA
Detection
Nano-biosensor

Graphical Abstract

A label-free and magnetically induced self-assembly electrochemical α-Fe2O3/Fe3O4@Au-ssDNA/BSA nano-biosensor was constructed for the detection of ctDNA, and the nano-biosensor exhibited excellent liner relationship, wider liner range, lower LOD, excellent stability, high selectivity, and superior accuracy.

1. Introduction

Circulating tumor DNA (ctDNA) is a DNA fragment released by malignant cells into systemic circulation [1,2], it derives from the apoptotic or necrotic cell turnover of cancer cells [3,4], and ctDNA detection can identify existence of various human tumors’ cells [5-7], therefore, ctDNA is an auspicious tumor biomarker [8,9], it holds immense promise for early preventions and prognostic treatments of tumors [10-12].

There are many detection approaches for ctDNA, such as digital pathological complete response (dPCR) [13,14], quantitative PCR (qPCR) [15], multiplex PCR (mPCR) [16], denaturing capillary electrophoresis (DCE) [17], fluorescence determination [18,19], electrochemical detection [20,21], etc. Among them, dPCR, qPCR, and mPCR are super sensitive and have been widely applied; however, their adaptation has limitations. Electrochemical detection reveals excellent reproducibility, stability, selectivity, stable storage [22-24], and more. Electrochemical detection is also ultra-sensitive and has a lower limit of detection (LOD), so it is more suitable for the prediction of tumors; it can thus be a beneficial supplement to PCR testing. Development of advanced materials, such as metal-organic frameworks (MOFs) [25] and nanomaterials [26,27], has expanded this horizon. Especially, nanomaterials have excellent properties for detection technology [28,29], such as ultrasensitivity and shorter detection time. Some researchers use nanomaterials for electrochemistry to enhance the detection sensitivity, widen the linear range, and reduce the LOD [30,31], and have made remarkable progress.

For realizing induced self-assembly, magnetic nanomaterials have received prominent attention. Due to their better biocompatibility, iron oxide nanomaterials are being widely applied in biomedicine. Among iron oxide nanomaterials, α-Fe2O3 and Fe3O4 are commonly used [32-34]. However, the excessive saturation magnetization (Ms) of Fe3O4 nanomaterials leads to their agglomeration, and the ultra-low Ms of α-Fe2O3 nanomaterials leads to a reduced effect of the applied magnetic field [35]. Therefore, α-Fe2O3/Fe3O4 magnetic nanocomposites (MNCs) possessing the appropriate Ms are highly favored. There are a few preparation methods for α-Fe2O3/Fe3O4 MNCs [36,37]; however, some of the preparation processes are complicated and apply hydrogen for reduction, resulting in a problem with preparation safety. Therein, the hydrothermal-calcination process is completely safe, has a short preparation cycle, and does not need special equipment.

Therefore, in this project, we successfully fabricated sheet-like α-Fe2O3/Fe3O4 MNCs via the hydrothermal-calcination process and applied them in electrochemical detection, which not only enhanced the electrochemical signals but also realized magnetically induced self-assembly. For further enhancing the electrical signals, gold reduced from chloroauric acid by sodium borohydride was led into the surfaces of α-Fe2O3/Fe3O4 MNCs. Subsequently, the aptamer (Apt) of single-stranded DNA (ssDNA) with sulfhydryl was immobilized onto the surfaces through Au-S bond to form electrochemical nano-biosensors referring our previous research [38], and the cyclic voltammetry (CV), electrochemical impedance spectroscopy (EIS), and differential pulse voltammetry (DPV) techniques were employed to measure the current signals and corresponding changes for every step of the construction process on the electrochemical workstation [39-41], and then the detection properties were evaluated. This research was an interdisciplinary study integrating material chemistry, pharmacology, biology, and medical testing, which provided a novel detection model for tumor markers and revealed the promising application prospect. The corresponding construction and detection processes have been shown in Scheme 1.

Construction and detection schematic of the electrochemical nano-biosensor for the detection of ctDNA.
Scheme 1.
Construction and detection schematic of the electrochemical nano-biosensor for the detection of ctDNA.

2. Materials and Methods

2.1. Materials

FeCl3·6H2O, NaH2PO4, glucose, HAuCl4⋅4H2O, C6H5Na3O7, NaBH4, KCl, trometamol (Tris), ethylene diamine tetraacetic acid (EDTA), K3Fe(CN)6, K4Fe(CN)6·3H2O, NaCl, KH2PO4, and Na2HPO4 were obtained from Sinopharm Chemical Reagent Co., Ltd. (Shanghai, China); polyethyleneimine (PEI) was purchased from Macklin Biochemical (Shanghai, China); tris-(2-carboxyethyl)-phosphine (TCEP) was supplied from Aladdin Reagent (Shanghai, China); phosphate buffered saline (PBS) was ordered from Servicebio Technology Co. Ltd. (Wuhan, China); absolute ethanol was obtained from Chengdu Chron Chemicals Co., Ltd. (Sichuan, China); bovine serum albumin (BSA) was purchased from Saiguo Biotech Co., Ltd. (Guangzhou, China). Human serum was provided by the Danyang People’s Hospital (Zhenjiang, China). All oligonucleotide sequences (Table 1) were supplied by Sangon Biotech Co., Ltd. (Shanghai, China).

Table 1. Oligonucleotides used in this project.
Oligonucleotide Sequence (5’-3’)
Circulating tumor DNA (ctDNA) TCG CTA TCA AGA CAT CTC CGA AAG CC
Single-stranded DNA (ssDNA) SH-(CH2)6-GG CTT TCG GAG ATG TCT TGA TAG CGA
Single-base mutant ctDNA (SBM-ctDNA) TCG CTA TCA AGA GAT CTC CGA AAG CC
Double-base mutant ctDNA (DBM-ctDNA) TCG GTA TCA AGA GAT CTC CGA AAG CC
Tribase mutant ctDNA (TBM-ctDNA) TCG GTA TCA AGA GAT CTC GGA AAG CC
Non-complementary ctDNA (NC-ctDNA) ACA GAA GAG GAG AAG TGA CAA TGC AT

2.2. Preparation and characterization of sheet-like α-Fe2O3/Fe3O4@Au MNCs

Firstly, α-Fe2O3 magnetic nanosheets (MNSs) were fabricated by the hydrothermal method. Typically, 0.541 g FeCl3·6H2O and 0.054 g NaH2PO4 were dissolved in 80 mL of deionized water. The obtained solution was transferred into a hydrothermal reactor (volume- 100 mL) for 24 h at 220°C. Thereafter, the reactor was naturally cooled, the mixture was centrifuged for 15 min at 10,000 rpm, and the product was alternately washed for thrice using absolute alcohol and deionized water. The product was dried for 12 h and ground; the α-Fe2O3 MNSs were obtained.

The sheet-like α-Fe2O3/Fe3O4 MNCs were prepared via the calcination process with α-Fe2O3 MNSs as the precursors. For this, 0.1 g α-Fe2O3 MNSs and 1.2 g glucose were uniformly mixed and placed into a crucible and calcined at 600°C for 4 h. It was then naturally cooled, and the solid was ground; the sheet-like α-Fe2O3/Fe3O4 MNCs were obtained.

The PEI containing terminal-NH2 groups forms a covalent bond with Au, and keeps the positive charge on the surfaces of the nanosheets, which allows the gold nanoparticles (AuNPs) to carry the negative charge to load onto the surfaces. For this, 1.5 g PEI was dissolved in 150 mL ultrapure water to form a homogeneous solution; 50 mg sheet-like α-Fe2O3/Fe3O4 MNCs were added to the PEI solution, ultrasonically dispersed for 30 min, and then the suspension was magnetically stirred for 2 h in 90oC water bath. Thereafter, it was centrifuged, the solid was washed with ultrapure water thrice, dried in a vacuum oven at 60°C, and the α-Fe2O3/Fe3O4-PEI MNCs were obtained.

α-Fe2O3/Fe3O4-PEI MNCs of 10 mg were dispersed in ultrapure water of 150 mL and dispersed for 10 min by ultrasound. Afterwards, 1 mL chloroauric acid solution (20 mg·mL-1) was put into the suspension and further sonicated for 30 min in an ice-bath, and then 9 mL NaBH4 solution (0.75 mg·mL-1) was added into it and stirred for another 15 min till the suspension turned to black [42], and after centrifugal separation and dry in vacuum oven at 60°C, the sheet-like α-Fe2O3/Fe3O4@Au MNCs were obtained.

The phase identifications of the α-Fe2O3 MNSs and sheet-like α-Fe2O3/Fe3O4 MNCs were characterized by X-ray diffraction (XRD), their morphologies and compositions were investigated by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). Their magnetic measurements were determined by the vibrating sample magnetometer (VSM).

2.3. Construction and detection evaluation of the biosensor

The ssDNA-adapted ctDNA was dissolved in TE buffer to form a homogeneous solution of 100 μM. A certain amount of the solution was diluted to 1 μM, and the 1 μM ssDNA solution was added to 1 μL of TCEP (10 mM) according to the molar ratio of 1:100. It was then reacted for 1 h to prompt the binding of ssDNA with AuNPs through the 5’-end sulfhydryl group. Then, 15 μL of the ultrapure water suspension containing α-Fe2O3/Fe3O4@Au MNCs of 20 mg∙mL-1 and 15 μL of TCEP-treated ssDNA were mixed and incubated for 13 h at 4°C, magnetically separated, and the supernatant was removed. The solid substances were washed with PBS to remove the uncombined ssDNA, the α-Fe2O3/Fe3O4@Au-ssDNA was obtained and dispersed in ultrapure water of 30 μL, then the suspension of 9 μL was dropped onto the glazed magnetic glass carbon electrode (MGCE) and dried, CV, EIS, and DPV techniques were employed to measure the current signal through an electrochemical workstation with MGCE, Pt electrode, and Ag/AgCl electrode as the working electrode, the counter, and the reference electrode, of which the scan voltage of CV was kept at -0.1 V-0.7 V, and the corresponding scan rate was controlled at 100 mV·s-1; while, the frequency range of EIS was 0.1 Hz–10 kHz, and the signal amplitude was 5 mV.

Subsequently, the as-prepared α-Fe2O3/Fe3O4@Au-ssDNA was added into 30 μL of BSA solution (2.5 mg∙mL-1), and incubated for 30 min at 4°C to shield the nonspecific sites to avoid any interference on the current signal, and the solid was magnetically separated and washed with PBS to remove the uncombined BSA. As expected, the resulting α-Fe2O3/Fe3O4@Au-ssDNA/BSA biosensors were constructed. For comprehending the amount of MGCE-α-Fe2O3/Fe3O4@Au-ssDNA probes on MGCE, their chrono coulometries were examined with or without hexaammineruthenium chloride (RuHex) at a scan rate of 0.01 V∙s-1 to 0.1 V∙s-1 for the peak anode currents (Ip) to the square root of the scanning rate ( v ).

The detection process of ctDNA was as follows: the α-Fe2O3/Fe3O4@Au-ssDNA/BSA biosensors obtained in the previous step were added to a 30 μL ctDNA solution (1 μM), and incubated for 15 min at 65 °C to accomplish the capture of ctDNA. Finally, the solids were washed with PBS to remove free ctDNA, and then the α-Fe2O3/Fe3O4@Au-ssDNA/BSA/ctDNA nanocomposites were obtained by magnetic separation. The nanocomposites were dispersed into 30 μL of ultrapure water, and according to usual practice, the suspension of the same volume was dropped onto the glazed MGCE, dried, and the electrochemical signal was examined.

In the construction and detection processes, for enhancing the current signals, the concentration of α-Fe2O3/Fe3O4@Au MNCs was optimized; for greatest degree immobilization of ssDNA and economy, the concentration of ssDNA was investigated; for suitable capture of ctDNA, the incubation temperature and the incubation time were examined; for the line range of the detection, and the relationship of the signal or change signal with concentration of ctDNA was measured; at the same time, the reproducibility, stability, and selectivity were also investigated. All experiments were executed thrice, and the average values, error bars, recoveries, and their relative standard deviations were calculated.

3. Results and Discussion

3.1. Characteristics of α-Fe2O3 MNSs, α-Fe2O3/Fe3O4 MNCs and α-Fe2O3/Fe3O4@Au MNCs

The characteristics of α-Fe2O3 MNSs, α-Fe2O3/Fe3O4 MNCs, and α-Fe2O3/Fe3O4@Au MNCs have been exhibited in Figure 1. Figure 1(a) displays the SEM morphology of α-Fe2O3 nanomaterials fabricated via the hydrothermal process. The α-Fe2O3 nanomaterials were round-structured nanosheets, and their diameter and thickness were approximately 230 nm and 130 nm. The size distribution of α-Fe2O3 MNSs was uniform. Figure 1(b) reveals the TEM image of sheet-like α-Fe2O3/Fe3O4 MNCs via the calcination process; their average diameter and thickness were around 220 nm and 130 nm, respectively. As expected, the average diameter and thickness had remained almost unchanged compared with those of α-Fe2O3 nanosheets.

(a) SEM morphology of α-Fe2O3 MNSs, (b) TEM images and (c) XRD pattern of α-Fe2O3/Fe3O4 MNCs (d) TEM images of α-Fe2O3/Fe3O4@Au MNCs, and (e) hysteresis loops of α-Fe2O3/Fe3O4 and α-Fe2O3/Fe3O4@Au MNCs.
Figure 1.
(a) SEM morphology of α-Fe2O3 MNSs, (b) TEM images and (c) XRD pattern of α-Fe2O3/Fe3O4 MNCs (d) TEM images of α-Fe2O3/Fe3O4@Au MNCs, and (e) hysteresis loops of α-Fe2O3/Fe3O4 and α-Fe2O3/Fe3O4@Au MNCs.

The XRD pattern of α-Fe2O3/Fe3O4 MNCs has been exhibited in Figure 1(c), most diffraction peaks at 24.1°, 33.2°, 35.6°, 40.9°, 49.5°, 54.1°, 62.4°, and 64.0° correspond to those of the α-Fe2O3 standard PDF card (JCPDS No. 33-0664). However, the intensity ratio of diffraction peaks at 33.2° and 35.6° was 7:8, which was a larger difference compared with that of 10:7 in the α-Fe2O3 standard PDF card. The reason was that the diffraction peak at 35.5o corresponding to Fe3O4 standard PDF card (JCPDS No. 03-0863), enhanced the diffraction at 35.5°, resulting in the change of intensity ratio for diffraction peaks at 33.2° and 35.6°, which confirmed the existence of Fe3O4 in the product, and that sheet-like α-Fe2O3/Fe3O4 MNCs were successfully prepared. Figure 1(d) displayed the TEM image of sheet-like α-Fe2O3/Fe3O4@Au MNCs. It could be seen that the particle size of AuNPs was around 8 nm, they attached to the surfaces of α-Fe2O3/Fe3O4@Au MNCs, and the distribution of AuNPs was uniform. AuNPs provided the linkage opportunity with ssDNA by the Au-S bond. The hysteresis loops of sheet-like α-Fe2O3/Fe3O4 and α-Fe2O3/Fe3O4@Au MNCs were measured and shown in Figure 1(e); their saturation magnetizations were 27.6 emu∙g-1 and 9.9 emu∙g-1. Obviously, the saturation magnetization of α-Fe2O3/Fe3O4@Au MNCs tremendously decreased compared with that of α-Fe2O3/Fe3O4 MNCs owing to the existence of Au, which suggested the successful loading of Au, which agreed with the conclusion from Figure 1(d).

3.2. Feasibility of the proposed biosensor

CV and EIS were employed to investigate the interfacial properties of the modified electrodes for each process of the biosensor, and the results have been demonstrated in Figure 2. From the CV examinations in Figure 2(a), after the α-Fe2O3/Fe3O4 nanosheets were self-assembled onto MGCE, the peak current of Ip (curve b) noticeably decreased compared with the bare electrode surface (curve a), which was due to the noteworthy steric hindrance formed by the nanosheets, hindering the accessibility of [Fe(CN)6]3-/4- to MGCE. In contrast, the current signal (curve c) of MGCE self-assembled α-Fe2O3/Fe3O4@Au MNCs remarkably increased compared with that of the α-Fe2O3/Fe3O4-modified electrode, and even surpassed that of the bare electrode (curve a). The reason was that AuNPs greatly improved the electrical conductivity of α-Fe2O3/Fe3O4@Au MNCs and effectively enhanced current signals, which also improved the detection sensitivity of the biosensor. When α-Fe2O3/Fe3O4@Au-ssDNA MNCs were assembled onto the MGCE, the append of ssDNA decreased the electroconductivity, resulting in the current signal (curve d) being reduced. When α-Fe2O3/Fe3O4@Au-ssDNA/BSA MNCs were further assembled onto the MGCE, the Ip was further decreased due to the poor electroconductivity of BSA (curve e). When ctDNA was captured onto probes and assembled onto the MGCE, the current signals (curve f) were decreased again. The corresponding EIS detections were examined and shown in Figure 2(b); the same principle was revealed, each step in the construction process similarly changed the transfer resistance (Rct). As was well-known, the stronger the electrical conductivity of the nanocomposites, the weaker the transfer resistance. Therefore, the transfer resistance of α-Fe2O3/Fe3O4@Au MNCs became weaker, and that of α-Fe2O3/Fe3O4@Au-ssDNA, α-Fe2O3/Fe3O4@Au-ssDNA/BSA, and α-Fe2O3/Fe3O4@Au-ssDNA/BSA-ctDNA became stronger step by step. In the EIS image, the semicircular diameter of EIS for α-Fe2O3/Fe3O4@Au MNCs became small, and those of α-Fe2O3/Fe3O4@Au-ssDNA, α-Fe2O3/Fe3O4@Au-ssDNA/BSA, and α-Fe2O3/Fe3O4@Au-ssDNA/BSA-ctDNA also became larger step by step. All the results agreed with the CV examination principle.

(a) Unmodified MGCE, (b) MGCE/Fe3O4/α-Fe2O3, (c) MGCE/Fe3O4/α-Fe2O3@Au, (d) MGCE/Fe3O4/α-Fe2O3@Au-ssDNA, (e) MGCE/Fe3O4/α-Fe2O3@Au-ssDNA/BSA, and f MGCE/Fe3O4/α-Fe2O3@Au-ssDNA/BSA/CYFRA 21-1 DNA.
Figure 2.
(a) Unmodified MGCE, (b) MGCE/Fe3O4/α-Fe2O3, (c) MGCE/Fe3O4/α-Fe2O3@Au, (d) MGCE/Fe3O4/α-Fe2O3@Au-ssDNA, (e) MGCE/Fe3O4/α-Fe2O3@Au-ssDNA/BSA, and f MGCE/Fe3O4/α-Fe2O3@Au-ssDNA/BSA/CYFRA 21-1 DNA.

The equivalent circuit for fitting the EIS curves was shown in the inset of Figure 2(b), wherein Rs was the solution resistance, Rct was the charge transfer resistance of the solution redox probe, W1 was the Warburg element, and Cd was the constant phase element. The electrochemical parameters of the EIS curves at different modification steps have been listed in Table 2. The time constant τ was related to the rate constant of the electrode reaction and the diffusion coefficient, which is commonly used to describe the rate of the electrode reaction and the charge transfer process. The formula for τ has been displayed in Eq. (1), and the results showed that the larger the resistance was, the smaller the value of τ was, which proved once again the success of the proposed electrochemical biosensor construction [43].

(1)
R c t C d = 1 / 2 π f max = τ

Table 2. Electrochemical parameters of the EIS spectra obtained in different modification steps of the electrode.
Electrode Rct (Ω) Rs (Ω) Cd (μF) W1 (σ) τ (s)
Bare MGCE(a) 669.7 53.93 0.30831 0.79329 206.47520
MGCE/Fe3O4/α-Fe2O3(b) 298.6 139.10 0.81480 0.41014 243.29928
MGCE/Fe3O4/α-Fe2O3@Au(c) 205.4 47.34 0.33188 0.54332 68.168152
MGCE/Fe3O4/α-Fe2O3@Au-ssDNA(d) 149.5 86.14 0.83465 0.46040 124.780175
MGCE/Fe3O4/α-Fe2O3@Au-ssDNA/BSA(e) 255.9 79.35 0.73609 0.42256 188.365431
MGCE/Fe3O4/α-Fe2O3@Au-ssDNA/BSA/tDNA(f) 288.0 117.00 0.75729 0.40984 218.09952

3.3. Analysis of the probe amount loaded on the electrode surface

The ssDNA attached to the magnetic α-Fe2O3/Fe3O4@Au nanocomposites through Au-S bonds played an important role in the detection of ctDNA by the electrochemical biosensor. Firstly, the CV curves (Figures 3a and b) of bare electrode and MGCE-α-Fe2O3/Fe3O4@Au-ssDNA at different scan rates (V) were examined to obtain their peak currents (Ip, μA), and their linear relationships were analyzed as (Figures 3c and d). Subsequently, based on the Randles-Sevcik Eq. (2), the electroactive surface area (A) of the modified electrode was calculated to be 0.0513 cm2. The surface excess Γ0 was obtained based on the integral Cottrell expression eq. (3) through the examination of chrono coulometry for MGCE-α-Fe2O3/Fe3O4@Au-ssDNA with or without RuHex, see Figure 3(e), which represented the amount of redox marker confined near the electrode surface. Finally, the electrode surface excess was converted to a ctDNA probe surface density of 1.15×1014 molecules⋅cm−2 based on Eq. (4) [44-46].

(2)
I p = 2.69 × 10 5 n 2 / 3 A D 1 / 2 v 1 / 2 C

(3)
Q = 2 n F A D 0 1 / 2 C o * π 1 / 2 t 1 / 2 + Q d l + n F A Γ 0

(4)
Γ D N A = Γ 0 ( z / m ) ( N A )

(a) CV curves and (b) the corresponding liner relationships of anodic peaks for bare MGCE, (c) CV curves and (d) the corresponding liner relationships of anodic peaks for MGCE-α-Fe2O3/Fe3O4@Au-ssDNA, and the resulting chrono coulometry (e) for MGCE-α-Fe2O3/Fe3O4@Au-ssDNA with or without RuHex (The different coloured bands express the different scan rates).
Figure 3.
(a) CV curves and (b) the corresponding liner relationships of anodic peaks for bare MGCE, (c) CV curves and (d) the corresponding liner relationships of anodic peaks for MGCE-α-Fe2O3/Fe3O4@Au-ssDNA, and the resulting chrono coulometry (e) for MGCE-α-Fe2O3/Fe3O4@Au-ssDNA with or without RuHex (The different coloured bands express the different scan rates).

3.4. Optimization of the key factors for the electrochemical biosensor

For obtaining the largest current signals, the concentration of α-Fe2O3/Fe3O4@Au MNCs for the immobilization of ssDNA was optimized, as shown in Figure 4(a). With the increase of α-Fe2O3/Fe3O4@Au concentration in ultrapure water, the electrochemical response increased, obviously, the increase of Au with the high electrical conductivity indeed promoted charge transfer rate, resulting in the increase of the current signal, and the concentration of α-Fe2O3/Fe3O4@Au MNCs increased to 10 mg∙mL-1, the electrochemical response reached largest; with the sequential increase of α-Fe2O3/Fe3O4@Au concentration, the electrochemical response decreased, the reason for which was that with the increase of α-Fe2O3/Fe3O4@Au, their agglomeration increased, leading to the increase of the steric hindrance and the decrease of the electrochemical response. Therefore, 10 mg∙mL-1 of α-Fe2O3/Fe3O4@Au was applied as the optimal condition.

(a) Optimization on the construction conditions of α-Fe2O3/Fe3O4@Au MNCs and (b) ssDNA concentrations, (c) hybridization temperature, and (d) hybridization time.
Figure 4.
(a) Optimization on the construction conditions of α-Fe2O3/Fe3O4@Au MNCs and (b) ssDNA concentrations, (c) hybridization temperature, and (d) hybridization time.

To a great degree, immobilization of ssDNA onto the surfaces of α-Fe2O3/Fe3O4@Au and the effect of ssDNA concentration were investigated, see Figure 4(b). With the increase of ssDNA concentration, the electrochemical response gradually reduced and achieved the stable value at 3 μM, which suggested that the binding of ssDNA onto α-Fe2O3/Fe3O4@Au MNCs had achieved the saturation state at ssDNA of 3 μM, and the larger ssDNA could not be immobilized onto the surfaces of α-Fe2O3/Fe3O4@Au nanocomposites, in other words, many ssDNA stayed in the solution, more ssDNA was meaningless. So, the concentration of ssDNA was selected at 3 μM.

For better capture of ctDNA by the α-Fe2O3/Fe3O4@Au-ssDNA/BSA, the incubation temperature and the incubation time of ctDNA in the suspension containing α-Fe2O3/Fe3O4@Au-ssDNA/BSA probes were detected, see Figures 4(c, d). From Figure 4(c), it can be seen that with the incubation temperature of ctDNA increasing from 37°C to 65°C, the electrochemical response gradually reduced and achieved the minimum value at 65°C; this suggested that the capture dose of ctDNA increased with the increase of the incubation temperature, and the electrical conductivity of the electrochemical system decreased. With the further increase of incubation temperature, the electrochemical response became large. On the contrary, the reason for this was that a higher temperature made the ctDNA inactive; the inactivated ctDNA could not be captured. Therefore, the electrical conductivity of the electrochemical detection system might not be decreased, and the electrochemical response becomes large. Therefore, the incubation temperature of ctDNA was selected at 65°C. Similarly, when the incubation temperature of ctDNA was 65°C, with the incubation time of ctDNA increasing from 5 to 15 min, the electrochemical response gradually reduced and achieved the minimum value at 15 min; and with the further extension of incubation time, the electrochemical response also became large. The reason for the similar rule was that under the incubation temperature of 65°C, the extension of the incubation time could contribute to the capture of ctDNA. However, the overlong time similarly resulted in the inactivation of ctDNA, which could result in the decrease of the electrical conductivity, so the incubation time of 15 min was selected.

To summarize, the optimized parameters of the electrochemical system for the detection of ctDNA were 10 mg∙mL-1 of α-Fe2O3/Fe3O4@Au concentration, 3 μM of ssDNA concentration, 65oC of ctDNA incubation temperature, and 15 min of incubation time.

3.5. Analytical performance

The DPV response technique was employed to assess the analytical property of the constructed electrochemical system for ctDNA detection, as revealed in Figure 5(a). Under the optimized conditions, the DPV responses were examined in Figure 5(a). It was not difficult to find that the DPV response gradually decreased while the ctDNA concentration increased from 10 pM to 1 μM, which suggested that the biosensors belonged to the “turn off” type detection mechanism. While, the current signal exhibited the robust linear relation with the logarithm of ctDNA concentration, as depicted in Figure 5(b), and the linear equation was I = - 2.62 lgCctDNA+138.35 with the higher variance (R2) of 0.998, Sum of Squares for Error (SSE) of 0.2549, Standard Errors (SE) of 0.0488 and 0.19967 for slope and intercept, and SSE/SE of 1.277. The LOD of 229 fM for the biosensor was calculated using equation of LOD=3 σ/m (σ referred the standard deviation (SD=±0.20) of the blank group response values (n=10) detected on different electrodes in five days; m denoted the slope (2.62) of the calibration curve; the confidence level was 95%); while, the LOQ of 763 fM for the biosensor was calculated using equation of LOQ=10 σ/m. Compared with other detection approaches (Table 3), the constructed nano-biosensor revealed a lower LOD and a wider linear range, especially, the operational process was simplified, and the operational period was also shortened.

DPV curves (a) of the biosensors for the detection of various standard solutions with various ctDNA concentrations, the corresponding linear relationship (b) and the corresponding inset for the non-linear relationship
Figure 5.
DPV curves (a) of the biosensors for the detection of various standard solutions with various ctDNA concentrations, the corresponding linear relationship (b) and the corresponding inset for the non-linear relationship
Table 3. Comparison of the reported electrochemical methods for ctDNA detection.
Detection approach Linear range (fM) LOD (fM) LOQ (fM) RSD (%) Reference
EIS 2–200 24.10 73.0 [20]
DPV 102–108 7.65 25.5 0.74–1.94 [28]
DPV 10-2–105 0.0033 0.011 0.41–1.69 [47]
DPV 1–105 0.33 1.10 1.10–4.60 [48]
DPV 104–109 229 763 0.19–1.15 This work

3.6. Analyses of reproducibility, stability, specificity, and spiked sample in clinical serum

The reproducibility was important for the biosensor; it reflected the reliability of measurement data, and its investigation was indispensable. Five electrodes dropped 9 μL of α-Fe2O3/Fe3O4@Au-ssDNA/BSA-ctDNA suspension incubated with a ctDNA concentration of 1 μM were recorded with DPV under the same optimal conditions, and the detections were repeated for thrice by various persons at different times. The peak currents were similar with RSD values of 1.13% for Person No. 1, 2.25% for Person No. 2, 1.61% for Person No. 3, and 1.68% for the total samples (Figure 6a), illustrating superior reproducibility of the biosensor. As everyone knows, the stability of the biosensor could reflect the resting period, which would offer a guarantee for the detection. The α-Fe2O3/Fe3O4@Au-ssDNA/BSA probes were dispersed in ultrapure water to form a suspension of 100 pg∙mL-1 and stored in 4oC refrigerator. Subsequently, the ctDNA was examined every 2 days. The detection errors of the response peak currents remained at -0.97%–1.47% in 14 days, as depicted in Figure 6(b), indicating excellent stability of the biosensors. The specificity was a key to evaluating whether the biosensors could or not be applied in the detection of ctDNA. The α-Fe2O3/Fe3O4@Au-ssDNA/BSA suspensions were incubated with 1 μM of ctDNA, SBM-ctDNA, DBM-ctDNA, TBM-ctDNA, and NC-ctDNA, respectively. And the peak currents were examined and displayed in Figure 6(c). As predicted, the peak currents for the detections of SBM-ctDNA, DBM-ctDNA, TBM-ctDNA, and NC-ctDNA were enhanced; only the peak current for the detection of ctDNA was decreased, revealing that only ctDNA could be captured onto the probes, suggesting the promising high selectivity.

(a) Reproducibility and (b) stability of the biosensors for ctDNA detection, and the (c) selectivity with 1 μM of ctDNA, SBM-ctDNA, DBM-ctDNA, TBM-ctDNA, and NC-ctDNA (The different colors indicate different storage times).
Figure 6.
(a) Reproducibility and (b) stability of the biosensors for ctDNA detection, and the (c) selectivity with 1 μM of ctDNA, SBM-ctDNA, DBM-ctDNA, TBM-ctDNA, and NC-ctDNA (The different colors indicate different storage times).

The various concentrations of ctDNA in human serums (10 pM– 106 pM) were prepared, and they were incubated with α-Fe2O3/Fe3O4@Au-ssDNA/BSA probes, as the experimental section described their peak currents were detected and listed in Table 4. The RSD values for them were 0.19%–1.15%, and their recovery rates for the detection of ctDNA were 96.26%–102.67%. All the data revealed that the detection of ctDNA using the biosensor was accurate and reliable, and suggested the significant clinical application value in the detection of ctDNA for the biosensors. At present, we are collecting the clinical samples; in the future, we will detect the concentrations of ctDNA for healthy persons and patients, and compare the results detected by the gold method. According to our estimation, all the work will be finished in about a year, and the related results will be reported.

Table 4. Detection and analysis of the spiked ctDNA samples in clinical human serum.
Spiked concentration of ctDNA (pM) I (μA) Detection concentration (pM) RSD (%) Recovery (%)
10 135.70 101.015 0.70 102.67
103 130.53 102.983 0.19 96.26
105 125.27 104.994 0.96 98.55
106 122.63 105.999 1.15 99.71

4. Conclusions

α-Fe2O3 MNSs were fabricated by the hydrothermal method at 220°C for 24 h, and the sheet-like α-Fe2O3/Fe3O4 MNCs, calcined at 600°C for 4 h with an average diameter of 220 nm, the average thickness of 130 nm, and the saturation magnetizations of 27.6 emu∙g-1, were prepared with the mass ratio of 1:12 for α-Fe2O3 MNSs and glucose. Subsequently, α-Fe2O3/Fe3O4@Au MNCs were prepared via the chloroauric acid reduction process with AuNPs of about 8 nm.

α-Fe2O3/Fe3O4@Au MNCs were employed to incubate with ssDNA and BSA and construct magnetic α-Fe2O3/Fe3O4@Au-ssDNA/BSA nano-biosensors with label-free and magnetically induced self-assembly for ctDNA detection. The nano-biosensors revealed an excellent linear relationship as I = -2.62 lgCctDNA+138.35 (the linear range of 10 pM–1 μM for ctDNA concentration) with R2 of 0.998, obtained a lower LOD of 229 fM, a lower LOQ of 763 fM, superior reproducibility (RSD=1.13%), excellent stability (the detection errors of -0.97%–1.47% in 14 days), and selectivity, which suggested the significant clinical application value in the detection of ctDNA for the biosensors.

Acknowledgment

This work was supported by the Postgraduate Research & Practice Innovation Program of Jiangsu Province (Grant No. KYCX24_4043).

CRediT authorship contribution statement

Yuxuan Bai: Literature search, Experimental studies, Data acquisition, Data analysis, Manuscript preparation. Zhixiang Lv: Design, Literature search, Data analysis, Manuscript preparation. Xuesong Cheng and Yawen Su: Experimental studies, Data analysis. Yongjin Li and Dawei He: Design, Clinical studies, Data acquisition, Manuscript editing and review. Ruijiang Liu: Literature search, Concepts, Definition intrllectual content, Manuscript editing and review.

Declaration of competing interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Data availability

Data will be made available on request.

Declaration of generative AI and AI-assisted technologies in the writing process

The authors confirm that there was no use of artificial intelligence (AI)-assisted technology for assisting in the writing or editing of the manuscript and no images were manipulated using AI.

References

  1. , , , , , , , , , , , , . Clinical value of preoperative circulating tumor DNA before surgery in patients with esophageal squamous cell carcinoma. European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2025;51:109625. https://doi.org/10.1016/j.ejso.2025.109625
    [Google Scholar]
  2. , . Circulating tumor DNA (ctDNA): Can it be used as a pan-cancer early detection test? Critical Reviews in Clinical Laboratory Sciences. 2024;61:241-253. https://doi.org/10.1080/10408363.2023.2275150
    [Google Scholar]
  3. , , , , , , . Oxygen vacancy-rich SnO2/CdIn2S4 heterojunction with self-primed multi-cycle amplification for sensitive ctDNA detection. Sensors and Actuators B: Chemical. 2025;425:136979. https://doi.org/10.1016/j.snb.2024.136979
    [Google Scholar]
  4. , , , , , , , , , , . Response prediction by mutation- or methylation-specific detection of ctDNA dynamics in pretreated metastatic colorectal cancer. Therapeutic Advances in Medical Oncology. 2023;15:17588359231200462. https://doi.org/10.1177/17588359231200462
    [Google Scholar]
  5. , , , , , , , , , . Longitudinal circulating tumor DNA monitoring in predicting response to short-course radiotherapy followed by neoadjuvant chemotherapy and camrelizumab in locally advanced rectal cancer: Data from a Phase Ⅲ clinical trial (UNION) Cancer Letters. 2025;611:217442. https://doi.org/10.1016/j.canlet.2025.217442
    [Google Scholar]
  6. , , , , , , , , . The hype around ctDNA guiding an informed perioperative therapeutic strategy in early-stage non-small cell lung cancer. Discover Oncology. 2025;16:100. https://doi.org/10.1007/s12672-025-01826-7
    [Google Scholar]
  7. , , , , , , , , , , , , , , , , , , , , , , , . Circulating tumour DNA in predicting and monitoring survival of patients with locally advanced rectal cancer undergoing multimodal treatment: Long-term results from a prospective multicenter study. EBioMedicine. 2025;112:105548. https://doi.org/10.1016/j.ebiom.2024.105548
    [Google Scholar]
  8. , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Ultrasensitive ctDNA detection for preoperative disease stratification in early-stage lung adenocarcinoma. Nature Medicine. 2025;31:70-76. https://doi.org/10.1038/s41591-024-03216-y
    [Google Scholar]
  9. , , , , , . A quadratic isothermal amplification fluorescent biosensor without intermediate purification for ultrasensitive detection of circulating tumor DNA. The Analyst. 2024;149:3396-3404. https://doi.org/10.1039/d4an00460d
    [Google Scholar]
  10. , , , , , . Circulating tumor DNA detection for recurrence monitoring of stage I non-small cell lung cancer treated with microwave ablation. Thoracic Cancer. 2025;16:e15534. https://doi.org/10.1111/1759-7714.15534
    [Google Scholar]
  11. , , , , , , , , , , , , . Circulating tumor DNA predicts venous thromboembolism in patients with cancers. Journal of Thrombosis and Haemostasis : JTH. 2025;23:139-148. https://doi.org/10.1016/j.jtha.2024.09.009
    [Google Scholar]
  12. , . Unlocking the potential of ctDNA for predicting tumor prognosis. International Journal of Surgery (London, England). 2025;111:1671-1672. https://doi.org/10.1097/JS9.0000000000002000
    [Google Scholar]
  13. , , , . Self-reinforced D-MOF and autocatalytic AuPd@SnS2 dual-wavelength electrochemiluminescence biosensor for detection of ctDNA and CEA. Sensors and Actuators B: Chemical. 2025;422:136679. https://doi.org/10.1016/j.snb.2024.136679
    [Google Scholar]
  14. , , , , , , , , , , , , , , , , , , , , , , , . Increased blood draws for ultrasensitive ctDNA and CTCs detection in early breast cancer patients. NPJ Breast Cancer. 2024;10:36. https://doi.org/10.1038/s41523-024-00642-6
    [Google Scholar]
  15. , , . Detection of ctDNA SNPs by nested real-time Taqman qPCR: A simulation study. Human Cell. 2022;35:2022-2025. https://doi.org/10.1007/s13577-022-00779-1
    [Google Scholar]
  16. , , , , , , , , , , , , , , , , . Post-surgical ctDNA-based molecular residual disease detection in patients with stage I uterine malignancies. Gynecologic Oncology. 2024;182:63-69. https://doi.org/10.1016/j.ygyno.2023.12.025
    [Google Scholar]
  17. , , , , , , , . Detection and quantification of ctDNA for longitudinal monitoring of treatment in non-small cell lung cancer patients using a universal mutant detection assay by denaturing capillary electrophoresis. Pathology Oncology Research : POR. 2022;28:1610308. https://doi.org/10.3389/pore.2022.1610308
    [Google Scholar]
  18. , , , , , , . Toehold and hairpin assembly-mediated tripedal DNA walker for circulating tumor DNA detection in human blood. Sensors and Actuators B: Chemical. 2025;424:136887. https://doi.org/10.1016/j.snb.2024.136887
    [Google Scholar]
  19. , , , , , , . Bioreaction-compatible bivariate lanthanide MOF sensor enables stimulus-multiresponsive platform for ctDNA on-site detection. Analytical Chemistry. 2024;96:10953-10961. https://doi.org/10.1021/acs.analchem.4c01207
    [Google Scholar]
  20. , , . Pre-enrichment-free detection of hepatocellular carcinoma-specific ctDNA via PDMS and MEMS-based microfluidic sensor. Mikrochimica Acta. 2024;191:229. https://doi.org/10.1007/s00604-024-06315-2
    [Google Scholar]
  21. , , , , , , , , , , . Electrochemical-fluorescent bimodal biosensor based on dual CRISPR-Cas12a multiple cascade amplification for ctDNA detection. Analytical Chemistry 2024 2024 Aug 12. https://doi.org/10.1021/acs.analchem.4c03012
    [Google Scholar]
  22. , , , , , , . CRISPR/Cas14a integrated with DNA walker based on magnetic self-assembly for human papillomavirus type 16 oncoprotein E7 ultrasensitive detection. Biosensors & Bioelectronics. 2025;272:117135. https://doi.org/10.1016/j.bios.2025.117135
    [Google Scholar]
  23. , , , , , , . Magnetically induced self-assembly electrochemical biosensor with ultra-low detection limit and extended measuring range for sensitive detection of HER2 protein. Bioelectrochemistry (Amsterdam, Netherlands). 2024;155:108592. https://doi.org/10.1016/j.bioelechem.2023.108592
    [Google Scholar]
  24. , , , . Ultra-trace determination of Cr (VI) ions in real water samples after electromembrane extraction through novel nanostructured polyaniline reinforced hollow fibers followed by electrothermal atomic absorption spectrometry. Microchemical Journal. 2018;143:212-219. https://doi.org/10.1016/j.microc.2018.08.014
    [Google Scholar]
  25. , , , . Highly efficient electrocatalytic water oxidation based on non-precious metal oxides/sulfides derived from a FeCoNi-metal organic framework. Journal of Alloys and Compounds. 2024;1002:175214. https://doi.org/10.1016/j.jallcom.2024.175214
    [Google Scholar]
  26. , , , , . Incorporation of CeO2 nanosheets into MnCoSx hollow nanorods for next generation supercapacitors. Energy & Fuels. 2025;39:4047-4058. https://doi.org/10.1021/acs.energyfuels.4c05048
    [Google Scholar]
  27. , , , , . Enhanced oxygen evolution reaction performance using amorphous hollow cerium-doped cobalt phosphate derived from ZIF-67 structures. Journal of Alloys and Compounds. 2024;1008:176697. https://doi.org/10.1016/j.jallcom.2024.176697
    [Google Scholar]
  28. , , , , , . A novel electrochemical biosensor for sensitive detection of non-small cell lung cancer ctDNA using NG-PEI-COFTAPB-TFPB as sensing platform and Fe-MOF for signal enhancement. Sensors and Actuators B: Chemical. 2022;350:130874. https://doi.org/10.1016/j.snb.2021.130874
    [Google Scholar]
  29. , , , , , , , , . Sensitive and selective ctDNA detection based on functionalized black phosphorus nanosheets. Biosensors & Bioelectronics. 2020;165:112384. https://doi.org/10.1016/j.bios.2020.112384
    [Google Scholar]
  30. , , , , , . Development of a magnetic α-Fe2O3/Fe3O4 heterogeneous nanorod-based electrochemical biosensing platform for HPV16 E7 oncoprotein detection. International Journal of Biological Macromolecules. 2025;284:138085. https://doi.org/10.1016/j.ijbiomac.2024.138085
    [Google Scholar]
  31. , , , , , . A type of self-assembled and label-free DNA-modified electrochemical biosensors based on magnetic α-Fe2O3/Fe3O4 heterogeneous nanorods for ultra-sensitive detection of CYP2C19*3. Bioelectrochemistry (Amsterdam, Netherlands). 2024;160:108792. https://doi.org/10.1016/j.bioelechem.2024.108792
    [Google Scholar]
  32. , , , , , , , . Enhanced cancer therapy using modified magnetic α-Fe2O3/Fe3O4 nanorods: Dual role in curcumin delivery and ferroptosis induction. Colloids and Surfaces. B, Biointerfaces. 2025;252:114689. https://doi.org/10.1016/j.colsurfb.2025.114689
    [Google Scholar]
  33. , . A novel polymer coated magnetic porous carbon nanocomposite derived from a metal-organic framework for multi-target environmental pollutants preconcentration. Journal of Chromatography. A. 2020;1634:461664. https://doi.org/10.1016/j.chroma.2020.461664
    [Google Scholar]
  34. , , . Simple synthesis of Fe3O4@Fe3S4 Nanocomposites coated with polyindole-polythiophene for high-performance supercapacitor. Journal of Composites and Compounds. 2023;5:20-24. https://doi.org/10.61186/jcc.5.1.4
    [Google Scholar]
  35. , , , , , , . Ultrasensitive determination of exosomal CD63: A novel label-free and self-assembled electrochemical aptasensor for cancer diagnosis based on magnetic heterostructured Fe3O4/α-Fe2O3 nanosheets. Materials Science in Semiconductor Processing. 2025;198:109802. https://doi.org/10.1016/j.mssp.2025.109802
    [Google Scholar]
  36. , , , , , , , . Magnetoresistance of sintered (Fe2O3)100x(Fe3O4)x ferrites. Journal of Magnetism and Magnetic Materials. 2004;272-276:1776-1777. https://doi.org/10.1016/j.jmmm.2003.12.745
    [Google Scholar]
  37. , , , . Construction of Fe3O4/Fe2O3 composite hollow spheres and their properties. Materials Letters. 2015;138:164-166. https://doi.org/10.1016/j.matlet.2014.09.120
    [Google Scholar]
  38. , , , , , . Ultrasensitive detection of PSA in human serum using Label-Free electrochemical biosensor with magnetically induced Self-Assembly based on α-Fe2O3/Fe3O4@Au nanocomposites. Microchemical Journal. 2024;201:110487. https://doi.org/10.1016/j.microc.2024.110487
    [Google Scholar]
  39. , , , , . Trimetallic (cobalt-nickel-copper) phosphates with cake ball-Like morphology for highly efficient oxygen evolution reaction. Journal of Alloys and Compounds. 2025;1024:180102. https://doi.org/10.1016/j.jallcom.2025.180102
    [Google Scholar]
  40. , , , , . Efficient electrocatalysts for OER: Amorphous cerium-doped cobalt sulfide with enhanced performance and durability. Surfaces and Interfaces. 2024;54:105108. https://doi.org/10.1016/j.surfin.2024.105108
    [Google Scholar]
  41. , , , , . A novel CoCuNi-sulfide nanocatalyst derived from trimetallic zeolitic imidazolate framework for boosting oxygen evolution reaction performance: Comparison study of sulfides and oxides. Materials Today Chemistry. 2024;42:102398. https://doi.org/10.1016/j.mtchem.2024.102398
    [Google Scholar]
  42. , , . Highly efficient electrochemical determination of propylthiouracil in urine samples after selective electromembrane extraction by copper nanoparticles-decorated hollow fibers. Biosensors & Bioelectronics. 2018;114:66-71. https://doi.org/10.1016/j.bios.2018.05.014
    [Google Scholar]
  43. , , , , . Fabrication of label-free and ultrasensitive electrochemical immunosensor based on molybdenum disulfide nanoparticles modified disposable ITO: An analytical platform for antibiotic detection in food samples. Food Chemistry. 2021;363:130245. https://doi.org/10.1016/j.foodchem.2021.130245
    [Google Scholar]
  44. , . Rational design of Ti3C2 MXene nanocomposite with bromophenol blue for efficient signal amplification: Sensitive electrochemical detection of cardiac troponin I in patient plasma. Sensors and Actuators B: Chemical. 2023;397:134668. https://doi.org/10.1016/j.snb.2023.134668
    [Google Scholar]
  45. , , . Electrochemical Sandwich-Type Aptasensor Based on the Multifunctional Catechol-Loaded Au/MIL-53(Fe) for detection of cardiac troponin I. ACS Applied Nano Materials. 2023;6:19239-19248. https://doi.org/10.1021/acsanm.3c03705
    [Google Scholar]
  46. , , , , , . DNA hairpin dimer-mediated dual-catalysis circuit for efficient and amplifiable electrochemical biosensing. Biosensors & Bioelectronics. 2025;278:117332. https://doi.org/10.1016/j.bios.2025.117332
    [Google Scholar]
  47. , , , , , , , , , , , . Electrochemical detection of ctDNA mutation in non-small cell lung cancer based on CRISPR/Cas12a system. Sensors and Actuators B: Chemical. 2022;362:131807. https://doi.org/10.1016/j.snb.2022.131807
    [Google Scholar]
  48. , , , . A FEN 1-assisted swing arm DNA walker for electrochemical detection of ctDNA by target recycling cascade amplification. Analytical Methods : Advancing Methods and Applications. 2022;14:1922-1927. https://doi.org/10.1039/d2ay00364c
    [Google Scholar]
Show Sections